Clinical Trials on Glabellar Crease
Total 10000 results
-
Jewish General HospitalTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
Hellenic Oncology Research GroupCompletedMetastatic Breast CancerGreece
-
Thomas HatschekCompletedMetastatic Breast CancerSweden
-
University of OklahomaCompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCEli Lilly and Company; AmgenCompletedMetastatic Breast CancerUnited States
-
Cancer Trials IrelandCompletedMetastatic Breast CancerIreland
-
Bristol-Myers SquibbCompletedAdvanced Breast CancerUnited States, Spain, Italy
-
Duke UniversityCelgene CorporationTerminatedMetastatic Breast CancerUnited States, China
-
University College, LondonNational Institute for Health Research, United KingdomCompletedBreast Cancer | Invasive Breast CancerUnited Kingdom
-
University of PisaCompleted
-
University of ChicagoGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterBaylor College of Medicine; Merck Sharp & Dohme LLC; Dana-Farber Cancer Institute and other collaboratorsCompletedMetastatic Breast CancerUnited States
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsUnknownMetastatic Breast CancerKorea, Republic of
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Qilu Pharmaceutical Co., Ltd.UnknownAdvanced Breast CancerChina
-
Vanderbilt-Ingram Cancer CenterWithdrawnMetastatic Breast Cancer
-
Jules Bordet InstituteCompletedInvasive Breast CancerBelgium
-
China Medical University HospitalTerminated
-
Accelerated Community Oncology Research NetworkHoffmann-La Roche; AstraZenecaCompletedMetastatic Breast CancerUnited States
-
PfizerTerminated
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsUnknownMetastatic Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsWithdrawn
-
Indiana UniversityNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)Completed
-
Chugai PharmaceuticalCompleted
-
BionovoCompletedMetastatic Breast Cancer
-
BionovoUnknownMetastatic Breast CancerUnited States
-
National Cancer Center, KoreaCompletedBreast Cancer MetastaticKorea, Republic of
-
King Faisal Specialist Hospital & Research CenterUnknownAdvanced Breast CancerSaudi Arabia
-
TTY BiopharmUnknownMetastatic Breast CancerTaiwan
-
German Breast GroupCompleted
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted
-
ARCAGY/ GINECO GROUPCompleted
-
National Cancer Center, KoreaCompleted
-
Hellenic Cooperative Oncology GroupTerminatedMetastatic Breast CancerGreece
-
PfizerCompleted
-
AstraZenecaCompletedAdvanced Breast CancerRussian Federation, Ukraine, Czech Republic
-
Ludwig-Maximilians - University of MunichCompleted
-
Medical University of ViennaUnknownMetastatic Breast CancerAustria
-
University Hospital TuebingenPaul Ehrlich Institute, Langen, GermanyCompletedMetastatic Breast CancerGermany
-
Klinikum WeissenfelsCompletedPrimary Breast CancerGermany
-
YM BioSciencesCompletedMetastatic Breast CancerSerbia
-
German Breast GroupGerman Adjuvant Breast Cancer GroupCompleted
-
Eli Lilly and CompanyCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Localized Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, Canada
-
National Cancer Institute (NCI)Southwest Oncology GroupCompletedRecurrent Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
National Cancer Institute (NCI)Not yet recruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma | Estrogen Receptor-Positive Breast Carcinoma
-
University of MalayaB-Crobes Laboratory (M) Sdn BhdRecruitingMastectomy Patient | Breast Cancer Early Stage Breast Cancer (Stage 1-3)Malaysia